Date: 2024/11/03 - 00:50
People with type 2 diabetes who use semaglutide drugs like Ozempic and Wegovy appear to have a lower risk of Alzheimer's disease, new evidence shows.
Certain genes influence the volume of key brain regions, which, in turn, could play a role in the development of Parkinson's disease and ADHD, a new study suggests.
Even occasional rounds of 30-minute exercise could help lower the risk of type 2 diabetes, as well as help people with this condition better maintain blood sugar control, a new study suggests.
Date: 2024/10/31 - 01:03
A collection of new papers highlight discoveries from the Human Tumor Atlas Network, a Cancer Moonshotâ„ initiative.
Date: 2024/10/19 - 19:40
NIH clinical trial results expand treatment options for this disease.
Findings in animals suggest a surgery-free treatment for cataracts.
NIH-supported clinical trial is the first positive trial for treatment of hereditary hemorrhagic telangiectasia.
NIH findings highlight critical gaps in treatment access in correctional facilities, where almost two-thirds of people have a substance use disorder.
Date: 2024/10/19 - 01:25
NIH-supported milestone will advance understanding of brain processes in larger animals.
Effort to identify risk factors for youth-onset type 2 diabetes to improve prevention and treatment.
